➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Baxter
Merck
McKesson
Johnson and Johnson
Boehringer Ingelheim

Last Updated: August 12, 2020

DrugPatentWatch Database Preview

Ziprasidone hydrochloride - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for ziprasidone hydrochloride and what is the scope of freedom to operate?

Ziprasidone hydrochloride is the generic ingredient in two branded drugs marketed by Upjohn, Apotex, Aurobindo Pharma Ltd, Cadila, Dr Reddys Labs Inc, Lupin Pharms, Macleods Pharms Ltd, Mylan, Sandoz Inc, Wockhardt Ltd, and Pfizer Inc, and is included in eleven NDAs. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Ziprasidone hydrochloride has fifty-nine patent family members in forty-nine countries.

There are twenty-three drug master file entries for ziprasidone hydrochloride. Twenty-three suppliers are listed for this compound.

Summary for ziprasidone hydrochloride
Recent Clinical Trials for ziprasidone hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Shanghai Jiao Tong University School of MedicinePhase 4
Shanghai Mental Health CenterPhase 4
University of ArizonaPhase 1

See all ziprasidone hydrochloride clinical trials

Pharmacology for ziprasidone hydrochloride
Paragraph IV (Patent) Challenges for ZIPRASIDONE HYDROCHLORIDE
Tradename Dosage Ingredient NDA Submissiondate
GEODON CAPSULE;ORAL ziprasidone hydrochloride 020825 2005-02-07

US Patents and Regulatory Information for ziprasidone hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lupin Pharms ZIPRASIDONE HYDROCHLORIDE ziprasidone hydrochloride CAPSULE;ORAL 077560-002 Mar 2, 2012 AB RX No No   Start Trial   Start Trial   Start Trial
Dr Reddys Labs Inc ZIPRASIDONE HYDROCHLORIDE ziprasidone hydrochloride CAPSULE;ORAL 077565-001 Mar 2, 2012 AB RX No No   Start Trial   Start Trial   Start Trial
Apotex ZIPRASIDONE HYDROCHLORIDE ziprasidone hydrochloride CAPSULE;ORAL 077561-002 Mar 2, 2012 AB RX No No   Start Trial   Start Trial   Start Trial
Upjohn GEODON ziprasidone hydrochloride CAPSULE;ORAL 020825-001 Feb 5, 2001 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ziprasidone hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Upjohn GEODON ziprasidone hydrochloride CAPSULE;ORAL 020825-002 Feb 5, 2001   Start Trial   Start Trial
Pfizer Inc GEODON ziprasidone hydrochloride SUSPENSION;ORAL 021483-001 Mar 29, 2006   Start Trial   Start Trial
Upjohn GEODON ziprasidone hydrochloride CAPSULE;ORAL 020825-004 Feb 5, 2001   Start Trial   Start Trial
Upjohn GEODON ziprasidone hydrochloride CAPSULE;ORAL 020825-001 Feb 5, 2001   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Boehringer Ingelheim
Medtronic
Harvard Business School
Mallinckrodt
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.